ADVERUM BIOTECHNOLOGIES INC (ADVM) Stock Earnings & Estimates
NASDAQ:ADVM - US00773U2078 - Common Stock
3.08 USD
+0.05 (+1.65%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 3.6M | 1M -72.22% | 19.367M 1,836.70% | 460.53K -97.62% | 437.07K -5.09% | 14.618M 3,244.54% | 72.33M 394.80% | 180.02M 148.89% | 244.09M 35.59% | 401.06M 64.31% | |
| EBITDA YoY % growth | -148.507M -5.79% | -118.147M 20.44% | -135.506M -14.69% | -198.9M -46.78% | -215.22M -8.21% | -262.14M -21.80% | -340.68M -29.96% | -392.7M -15.27% | -381.48M 2.86% | -318.24M 16.58% | -214.2M 32.69% | |
| EBIT YoY % growth | -155.035M -6.90% | -123.791M 20.15% | -139.159M -12.41% | -188.607M -35.53% | -183.24M 2.85% | -178.443M 2.62% | -213.658M -19.73% | -175.264M 17.97% | -89.811M 48.76% | -65.153M 27.46% | 63.306M 197.16% | |
| Operating Margin | N/A | -3,438.64% | -13,915.90% | -973.86% | -39,788.98% | -40,827.15% | -1,461.61% | -242.31% | -49.89% | -26.69% | 15.78% | |
| EPS YoY % growth | -15.50 -4.73% | -11.60 25.16% | -5.65 51.29% | -5.37 5.04% | -2.05 61.71% | -2.09 -1.62% | -1.94 7.01% | -1.70 12.61% | -0.95 44.09% | -0.01 98.92% | 1.04 10,267.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.50 -15.34% | -0.62 68.57% | -0.42 81.19% | -0.39 83.22% | -0.43 71.09% | -0.44 27.98% |
| Revenue Q2Q % growth | -100.00% | 19.367M | -100.00% | |||
| EBITDA Q2Q % growth | -52.02M -64.65% | -53.04M -36.12% | -55.08M -25.58% | -56.1M -14.58% | -54.06M -3.92% | -56.1M -5.77% |
| EBIT Q2Q % growth | -53.398M -55.06% | -36.103M 15.29% | -55.08M -28.52% | -57.375M -16.36% | -57.375M -7.45% | -58.523M -62.10% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -2.34 -162.92% | -2.29 | -0.05 | -2.11% |
| Q1 2025 Q2Q % growth | -2.25 -50.00% | -1.85 | -0.40 | -21.57% |
| Q4 2024 Q2Q % growth | -1.96 14.78% | -1.39 | -0.57 | -41.41% |
| Q3 2024 Q2Q % growth | -1.30 60.61% | -1.33 | 0.03 | 2.50% |
| Q2 2024 Q2Q % growth | -0.89 71.29% | -1.50 | 0.61 | 40.56% |
| Q1 2024 Q2Q % growth | -1.50 48.28% | -1.43 | -0.07 | -4.70% |
| Q4 2023 Q2Q % growth | -2.30 30.30% | -3.43 | 1.13 | 33.02% |
| Q3 2023 Q2Q % growth | -3.30 17.50% | -3.21 | -0.09 | -2.65% |
| Q2 2023 Q2Q % growth | -3.10 29.55% | -3.35 | 0.25 | 7.57% |
| Q1 2023 Q2Q % growth | -2.90 23.68% | -3.27 | 0.37 | 11.26% |
| Q4 2022 Q2Q % growth | -3.30 5.71% | -3.70 | 0.40 | 10.73% |
| Q3 2022 Q2Q % growth | -4.00 -2.56% | -3.52 | -0.48 | -13.67% |
| Q2 2022 Q2Q % growth | -4.40 2.22% | -3.47 | -0.93 | -26.87% |
| Q1 2022 Q2Q % growth | -3.80 -31.03% | -3.16 | -0.64 | -20.18% |
| Q4 2021 Q2Q % growth | -3.50 10.26% | -3.50 | 0.00 | 0.06% |
| Q3 2021 Q2Q % growth | -3.90 -25.81% | -3.83 | -0.07 | -1.96% |
| Q2 2021 Q2Q % growth | -4.50 -25.00% | -3.97 | -0.53 | -13.45% |
| Q1 2021 Q2Q % growth | -2.90 6.45% | -3.89 | 0.99 | 25.40% |
| Q4 2020 Q2Q % growth | -3.90 -34.48% | -3.29 | -0.61 | -18.38% |
| Q3 2020 Q2Q % growth | -3.10 -24.00% | -3.50 | 0.40 | 11.48% |
| Q2 2020 Q2Q % growth | -3.60 -56.52% | -2.89 | -0.71 | -24.57% |
| Q1 2020 Q2Q % growth | -3.10 -34.78% | -2.79 | -0.31 | -10.92% |
| Q4 2019 Q2Q % growth | -2.90 | -3.00 | 0.10 | 3.39% |
| Q3 2019 Q2Q % growth | -2.50 | -2.70 | 0.20 | 7.26% |
| Q2 2019 Q2Q % growth | -2.30 | -3.00 | 0.70 | 23.30% |
| Q1 2019 Q2Q % growth | -2.30 | -2.74 | 0.44 | 16.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1M | 102K | 898K | 880.39% |
| Q2 2024 Q2Q % growth | 77.224K | -77.224K | -100.00% | |
| Q1 2024 Q2Q % growth | -100.00% | 74.317K | -74.317K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 7.5M | 58.65K | 7.441M | 12,687.72% |
| Q4 2020 Q2Q % growth | 78.203K | -78.203K | -100.00% | |
| Q3 2020 Q2Q % growth | -100.00% | 67.024K | -67.024K | -100.00% |
| Q2 2020 Q2Q % growth | 96.9K | -96.9K | -100.00% | |
| Q1 2020 Q2Q % growth | 86.129K | -86.129K | -100.00% | |
| Q4 2019 Q2Q % growth | 146.197K | -146.197K | -100.00% | |
| Q3 2019 Q2Q % growth | 250K | 180.203K | 69.797K | 38.73% |
| Q2 2019 Q2Q % growth | 308.04K | -308.04K | -100.00% | |
| Q1 2019 Q2Q % growth | 316.2K | -316.2K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 14.28% | 2.56% |
| Revenue | N/A | N/A | 9893.29% | 11892.2% |